CN106153792A - 一种香加皮的指纹图谱及其质量检测方法 - Google Patents
一种香加皮的指纹图谱及其质量检测方法 Download PDFInfo
- Publication number
- CN106153792A CN106153792A CN201510128555.9A CN201510128555A CN106153792A CN 106153792 A CN106153792 A CN 106153792A CN 201510128555 A CN201510128555 A CN 201510128555A CN 106153792 A CN106153792 A CN 106153792A
- Authority
- CN
- China
- Prior art keywords
- methanol
- solution
- reference substance
- cortex periplocae
- need testing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000007639 printing Methods 0.000 title claims description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 130
- WZUODJNEIXSNEU-UHFFFAOYSA-N 2-Hydroxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(O)=C1 WZUODJNEIXSNEU-UHFFFAOYSA-N 0.000 claims abstract description 58
- 238000012360 testing method Methods 0.000 claims abstract description 55
- 239000013558 reference substance Substances 0.000 claims abstract description 53
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims abstract description 38
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 235000001368 chlorogenic acid Nutrition 0.000 claims abstract description 27
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims abstract description 26
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims abstract description 26
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims abstract description 26
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims abstract description 26
- 229940074393 chlorogenic acid Drugs 0.000 claims abstract description 26
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims abstract description 26
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims abstract description 26
- 238000002156 mixing Methods 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000006228 supernatant Substances 0.000 claims abstract description 7
- 239000000470 constituent Substances 0.000 claims abstract description 5
- 238000004364 calculation method Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 75
- 238000003556 assay Methods 0.000 claims description 22
- 238000001514 detection method Methods 0.000 claims description 22
- 230000014759 maintenance of location Effects 0.000 claims description 17
- 239000012071 phase Substances 0.000 claims description 16
- 229910019142 PO4 Inorganic materials 0.000 claims description 14
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 14
- 239000010452 phosphate Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 9
- 241001406327 Periploca sepium Species 0.000 claims description 8
- 239000011550 stock solution Substances 0.000 claims description 8
- 231100000614 poison Toxicity 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 239000002574 poison Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 71
- 239000012567 medical material Substances 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000003643 water by type Substances 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000007621 cluster analysis Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000000513 principal component analysis Methods 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 241000753128 Periploca <moth> Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 3
- 231100000567 intoxicating Toxicity 0.000 description 3
- 230000002673 intoxicating effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019133 Hangover Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- FGDQGIKMWOAFIK-UHFFFAOYSA-N acetonitrile;phosphoric acid Chemical compound CC#N.OP(O)(O)=O FGDQGIKMWOAFIK-UHFFFAOYSA-N 0.000 description 2
- 229940097217 cardiac glycoside Drugs 0.000 description 2
- 239000002368 cardiac glycoside Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 description 2
- LBDROUOCQSGOFI-UHFFFAOYSA-N methanol;phosphoric acid Chemical compound OC.OP(O)(O)=O LBDROUOCQSGOFI-UHFFFAOYSA-N 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000013441 quality evaluation Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- -1 similarity Chemical compound 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 229930002534 steroid glycoside Natural products 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- 238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
- 238000001295 Levene's test Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 238000011869 Shapiro-Wilk test Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510128555.9A CN106153792B (zh) | 2015-03-23 | 2015-03-23 | 一种香加皮的指纹图谱及其质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510128555.9A CN106153792B (zh) | 2015-03-23 | 2015-03-23 | 一种香加皮的指纹图谱及其质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106153792A true CN106153792A (zh) | 2016-11-23 |
CN106153792B CN106153792B (zh) | 2019-12-31 |
Family
ID=58063899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510128555.9A Active CN106153792B (zh) | 2015-03-23 | 2015-03-23 | 一种香加皮的指纹图谱及其质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106153792B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107607649A (zh) * | 2017-09-17 | 2018-01-19 | 贵阳中医学院 | 一种黑骨藤的检测方法 |
CN113588818A (zh) * | 2021-07-22 | 2021-11-02 | 安领生物医药(苏州)有限公司 | Sd大鼠血浆中北五加皮苷m含量的测定方法 |
-
2015
- 2015-03-23 CN CN201510128555.9A patent/CN106153792B/zh active Active
Non-Patent Citations (2)
Title |
---|
曾友志 等: "RP-HPLC测定3种五加皮中的绿原酸", 《华西药学杂志》 * |
李丹毅 等: "建立评价香加皮质量的RP-HPLC色谱指纹图谱分析方法", 《中药材》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107607649A (zh) * | 2017-09-17 | 2018-01-19 | 贵阳中医学院 | 一种黑骨藤的检测方法 |
CN107607649B (zh) * | 2017-09-17 | 2020-07-03 | 贵阳中医学院 | 一种黑骨藤的检测方法 |
CN113588818A (zh) * | 2021-07-22 | 2021-11-02 | 安领生物医药(苏州)有限公司 | Sd大鼠血浆中北五加皮苷m含量的测定方法 |
CN113588818B (zh) * | 2021-07-22 | 2023-08-29 | 安领生物医药(苏州)有限公司 | Sd大鼠血浆中北五加皮苷m含量的测定方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106153792B (zh) | 2019-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103257188B (zh) | 一种复方血栓通制剂生物活性色谱指纹图谱的构建方法 | |
CN106526002B (zh) | 参芪降糖制剂含量测定方法及其在整体质量控制中的应用 | |
Cao et al. | A rapid and sensitive assay for determining the main components in processed fructus Corni by UPLC–Q-TOF-MS | |
CN109374762A (zh) | 一种基于代谢组学鉴别广陈皮与陈皮品种的方法 | |
Xia et al. | High‐performance liquid chromatography based chemical fingerprint analysis and chemometric approaches for the identification and distinction of three endangered Panax plants in Southeast Asia | |
CN111487347B (zh) | 枳术颗粒指纹图谱的检测方法 | |
CN107340348A (zh) | 一种白及药材hplc指纹图谱的建立方法 | |
CN109444290A (zh) | 车前草药材uplc特征图谱的构建方法和检测方法 | |
Liu et al. | Simultaneous determination of 18 chemical constituents in traditional Chinese medicine of antitussive by UPLC–MS-MS | |
CN104062374A (zh) | 益气补肾的中药组合物的检测方法 | |
CN108445124A (zh) | 衢枳壳hplc指纹图谱的建立方法、标准指纹图谱及应用 | |
CN107132304B (zh) | 一种远志药材指纹图谱及指标性成分含量测定的方法 | |
CN103808835A (zh) | Hplc-dad法同时测定四物汤煎剂中10种化学成分含量的方法 | |
CN103822975B (zh) | 一种党参方的生脉制剂的检测方法 | |
CN101788537B (zh) | 鸡眼睛药材中鞣花酸类成分的含量测定方法 | |
CN113419000B (zh) | 一种基于非靶向代谢组学鉴别25头与80头以下三七的方法 | |
Farhadi et al. | Metabolic differences of two Ferula species as potential sources of galbanum: An NMR‐based metabolomics study | |
Liu et al. | In-depth profiling, nontargeted metabolomic and selective ion monitoring of eight chemical markers for simultaneous identification of different part of Eucommia ulmoides in 12 commercial products by UPLC/QDa | |
CN106153792A (zh) | 一种香加皮的指纹图谱及其质量检测方法 | |
CN106918655A (zh) | 一种远志uplc测定方法 | |
Pang et al. | Discrimination for geographical origin of Panax quinquefolius L. using UPLC Q‐Orbitrap MS‐based metabolomics approach | |
CN107782798B (zh) | 一种应用双波长uplc检测芪参益气滴丸的方法 | |
CN106124682A (zh) | 一种刺五加注射液的成分检验方法 | |
CN110261512A (zh) | 基于代谢组学的维药昆仑雪菊质量评价方法 | |
Mu et al. | Simultaneous determination of nine phenolic compounds in imitation wild Dendrobium officinale samples using ultrahigh-performance liquid chromatography–tandem mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Applicant after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Applicant before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240502 Address after: 300410 2 East Road Puji River, Beichen District, Tianjin (Tsun Li modern Chinese medicine city) Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Country or region after: China Patentee after: Tianjin Tasly Modern TCM Resources Co.,Ltd. Address before: 300410 Tianjin Beichen District Huaihe road and Ting Jiang West Road intersection heaven proud of the park Legal Center Intellectual Property Department Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Country or region before: China |